Australia's NHMRC Read 176 Papers and Published What It Found

The 2015 systematic review by Australia's peak health research body examined more clinical evidence on homeopathy than any previous government-commissioned report — and stated its conclusions without qualification.

The Document and What Preceded It

The Australian National Health and Medical Research Council is the Commonwealth government body responsible for funding medical research and issuing health guidelines. In March 2015 it released a document titled NHMRC Information Paper: Evidence on the Effectiveness of Homeopathy for Treating Health Conditions, accompanied by a plain-language summary for the public. Together they represented the output of a review process that had begun several years earlier and had, before reaching publication, already generated one shelved draft.

The conclusions section, where a review states its own finding rather than a summary of it.Photo: MART PRODUCTION / Pexels

That earlier draft dates to 2012. An independent contractor completed it for the NHMRC, but the council chose not to release it as a finalised report. The reason the NHMRC gave publicly was methodological: the draft did not meet the council's own standards for a systematic review. A second process was commissioned, conducted under the council's direct oversight, with a revised protocol specifying in advance what evidence would be included and how it would be assessed. The 2012 document surfaced later through freedom-of-information requests and attracted attention from homeopathy advocacy groups who argued it reached broadly similar conclusions, making the decision not to publish it appear outcome-driven. The NHMRC maintained that the procedural objections were legitimate and applied the same evidentiary threshold to both exercises.

The Scope and Methodology of the 2015 Review

The 2015 review set out to answer a single, bounded question: whether homeopathy is effective for any health condition when compared with placebo or other control conditions. The scope was deliberately broad. Researchers working under the NHMRC's oversight identified 176 individual studies, drawn from systematic reviews already published in the peer-reviewed literature rather than from a new sweep of primary trials. Each systematic review had itself synthesised multiple randomised controlled trials; the NHMRC process was therefore a review of reviews — a methodology the council described as appropriate given the volume of existing secondary literature.

The 68 health conditions examined ranged across acute and chronic presentations: respiratory conditions, mental health complaints, musculoskeletal pain, childhood ailments, dermatological conditions and several others. For each condition the team assessed whether the body of evidence was of sufficient quality to draw a conclusion, and whether that evidence demonstrated any effect beyond placebo.

The quality threshold the NHMRC applied was explicit and pre-specified. Studies were assessed on sample size, blinding, randomisation and outcome reporting. A body of evidence had to clear that threshold before any conclusion — positive or negative — could be drawn. Where evidence was of poor quality or the trials too small, the NHMRC declined to characterise the result as either supportive or unsupportive of homeopathy; instead it recorded that no reliable evidence existed.

Kent's rubrics are arranged by symptom rather than by remedy, which is why the book is a repertory and not a materia medica.Photo: Richard REVEL / Pexels

The Conclusions as Stated

The published 2015 Information Paper stated that, based on all the evidence considered, there were no health conditions for which there was reliable evidence that homeopathy was more effective than control treatment or placebo. That sentence — essentially unhedged — was the document's central finding. It applied across all 68 conditions examined.

For 61 of the 68 conditions the council concluded that the available evidence was of insufficient quality to make any determination. For the remaining conditions, where better-quality evidence did exist, the conclusion was consistent: no effect beyond placebo was demonstrated. The document did not state that homeopathy was proven ineffective in all circumstances; it stated that no reliable evidence supported effectiveness in any of the circumstances examined.

The NHMRC was equally direct in its recommendations. The Information Paper advised Australians who were considering using homeopathy for any serious or chronic condition to consult a qualified medical practitioner, and it stated that if a health professional recommended homeopathy, patients should ask about the evidence base. The document explicitly warned that choosing homeopathy over treatments of established effectiveness carried health risks.

Methodology Criticisms and the Council's Responses

Practitioners and organisations within the homeopathic profession objected to several aspects of the review's design. The most substantive criticism concerned the quality threshold itself: the NHMRC required a minimum sample size of 150 participants in a study for it to be considered reliable, a figure critics argued excluded a large portion of the available trial literature in a way that was not standard practice in medical systematic reviews. The NHMRC's position was that small trials are at elevated risk of bias and that results from them cannot be generalised.

A second line of criticism addressed the decision to work from existing systematic reviews rather than primary trials directly. Opponents argued this introduced a layer of filtering that could compound earlier methodological decisions made by other researchers. The NHMRC acknowledged the limitation but maintained that the approach was appropriate given the council's resources and the volume of published secondary literature.

The homeopathy advocacy body the Australian Homeopathic Association made formal submissions during and after the process. The NHMRC published responses to those submissions. A subsequent review of the NHMRC's handling of the process, conducted by an external consultant in 2019, found no evidence of bias or procedural irregularity in the 2015 review's conduct, though it noted that documentation around the decision not to publish the 2012 draft had been inadequate.

Placement in the Wider Record

The NHMRC review was not the first structured examination of the evidence base. Klaus Linde and colleagues published a meta-analysis in The Lancet in 1997 ↗ that found results not compatible with the hypothesis that homeopathy had no effect, while noting that the evidence was insufficient to identify which conditions might respond. Aijing Shang and colleagues, also in The Lancet, published a 2005 meta-analysis concluding that the effects seen in homeopathy trials were consistent with publication bias and methodological weaknesses in lower-quality studies.

The 2015 NHMRC report was distinctive in several respects: its government mandate, its public-health framing, its explicit consumer-facing language and its breadth across 68 conditions. No comparable government review has subsequently replaced or superseded it in Australia. The Information Paper remains publicly available on the NHMRC's website and is the document most frequently cited by Australian health bodies when addressing questions about homeopathy's evidence status.